These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 3529930)

  • 1. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
    Shimizu K; Hara K; Kunii A
    Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
    Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
    J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
    Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
    Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural effusion in Hodgkin's lymphoma. Report of a case with immunoperoxidase studies.
    Peterson IM; Raible M
    Acta Cytol; 1991; 35(3):300-5. PubMed ID: 1710403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of non-Hodgkin's lymphoma following therapy for Hodgkin's disease.
    Kim HD; Bedetti CD; Boggs DR
    Cancer; 1980 Dec; 46(12):2596-602. PubMed ID: 7448698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma following successful treatment of Hodgkin's disease.
    Amin R; Anthony P
    Clin Radiol; 1986 Sep; 37(5):483-6. PubMed ID: 3757421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
    Simrell CR; Boccia RV; Longo DL; Jaffe ES
    Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease coexistent with plasma cell dyscrasia.
    Zarate-Osorno A; Medeiros LJ; Jaffe ES
    Arch Pathol Lab Med; 1992 Sep; 116(9):969-72. PubMed ID: 1524465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Dorfman RF; Gatter KC; Pulford KA; Mason DY
    Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "syncytial variant" of nodular sclerosing Hodgkin's disease.
    Strickler JG; Michie SA; Warnke RA; Dorfman RF
    Am J Surg Pathol; 1986 Jul; 10(7):470-7. PubMed ID: 2425645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.